The latest research related to the treatment of patients with psoriatic arthritis is often first made public at the American College of Rheumatology (ACR) annual meeting. In this CME activity, Dr. Roy Fleischmann of the University of Texas Southwestern Medical Center at Dallas discusses three posters presented at ACR Convergence 2020. Dr. Fleischmann first summarizes the methods and results of each of these posters, then provides his own thoughts as to the importance of the research findings and implications for clinical practice in the treatment of patients with psoriatic arthritis.
0.75 AMA PRA Category 1 CreditsTM
This activity is intended for a national audience of rheumatologists, dermatologists, primary care physicians and other healthcare providers who manage patients with psoriatic arthritis.
This activity is supported by an educational grant from Janssen Biotech, Inc.